天弘国证生物医药ETF发起式联接A(011040)资产配置 |
|
报告日期 |
股票(元) |
债券(元) |
基金总资产(元) |
基金净值(元) |
股票占净值比 |
2024/3/31 |
43,710,200 |
1,216,030 |
1,046,000,000 |
1,034,150,000 |
4% |
2023/12/31 |
54,331,000 |
1,516,520 |
1,220,210,000 |
1,208,370,000 |
5% |
2023/9/30 |
25,418,900 |
1,108,830 |
1,294,590,000 |
1,257,760,000 |
2% |
2023/6/30 |
44,916,800 |
1,213,320 |
1,240,980,000 |
1,226,170,000 |
4% |
2023/3/31 |
37,157,600 |
- |
1,074,340,000 |
1,063,400,000 |
3% |
2022/12/31 |
14,591,600 |
202,568 |
1,075,130,000 |
1,041,580,000 |
1% |
2022/9/30 |
10,578,200 |
- |
1,100,650,000 |
1,072,120,000 |
1% |
2022/6/30 |
28,875,400 |
- |
1,048,780,000 |
1,020,050,000 |
3% |
2022/3/31 |
20,255,200 |
- |
926,100,000 |
912,942,000 |
2% |
2021/12/31 |
36,747,000 |
- |
1,057,100,000 |
1,046,600,000 |
4% |
2021/9/30 |
650,504,000 |
- |
700,325,000 |
689,590,000 |
94% |
2021/6/30 |
612,580,000 |
298,600 |
680,996,000 |
639,925,000 |
96% |
2021/3/31 |
365,513,000 |
- |
393,807,000 |
385,654,000 |
95% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。